nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—MTNR1A—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0709	0.0709	CbGpPWpGaD
Melatonin—MTNR1B—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0709	0.0709	CbGpPWpGaD
Melatonin—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0564	0.0564	CbGpPWpGaD
Melatonin—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0564	0.0564	CbGpPWpGaD
Melatonin—MTNR1A—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0429	0.0429	CbGpPWpGaD
Melatonin—MTNR1B—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0429	0.0429	CbGpPWpGaD
Melatonin—MTNR1A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.0243	0.0243	CbGpPWpGaD
Melatonin—MTNR1B—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.0243	0.0243	CbGpPWpGaD
Melatonin—MTNR1B—Signaling by GPCR—CXCL11—nasal cavity cancer	0.022	0.022	CbGpPWpGaD
Melatonin—MTNR1A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.022	0.022	CbGpPWpGaD
Melatonin—CALR—Adaptive Immune System—FRS2—nasal cavity cancer	0.0209	0.0209	CbGpPWpGaD
Melatonin—ESR1—Signaling by ERBB4—FRS2—nasal cavity cancer	0.0159	0.0159	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—CXCL11—nasal cavity cancer	0.013	0.013	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—CXCL11—nasal cavity cancer	0.013	0.013	CbGpPWpGaD
Melatonin—CALR—Immune System—FRS2—nasal cavity cancer	0.0127	0.0127	CbGpPWpGaD
Melatonin—CALR—Disease—FRS2—nasal cavity cancer	0.0117	0.0117	CbGpPWpGaD
Melatonin—CALM3—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0113	0.0113	CbGpPWpGaD
Melatonin—CALM1—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0109	0.0109	CbGpPWpGaD
Melatonin—CALM2—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0109	0.0109	CbGpPWpGaD
Melatonin—CALM3—Downstream signal transduction—FRS2—nasal cavity cancer	0.0106	0.0106	CbGpPWpGaD
Melatonin—CALM3—Signaling by FGFR—FRS2—nasal cavity cancer	0.0106	0.0106	CbGpPWpGaD
Melatonin—CALM3—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0105	0.0105	CbGpPWpGaD
Melatonin—CALM3—DAP12 signaling—FRS2—nasal cavity cancer	0.0105	0.0105	CbGpPWpGaD
Melatonin—CALM2—Downstream signal transduction—FRS2—nasal cavity cancer	0.0103	0.0103	CbGpPWpGaD
Melatonin—CALM1—Downstream signal transduction—FRS2—nasal cavity cancer	0.0103	0.0103	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR—FRS2—nasal cavity cancer	0.0102	0.0102	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR—FRS2—nasal cavity cancer	0.0102	0.0102	CbGpPWpGaD
Melatonin—CALM1—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0102	0.0102	CbGpPWpGaD
Melatonin—CALM2—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0102	0.0102	CbGpPWpGaD
Melatonin—CALM1—DAP12 signaling—FRS2—nasal cavity cancer	0.0101	0.0101	CbGpPWpGaD
Melatonin—CALM2—DAP12 signaling—FRS2—nasal cavity cancer	0.0101	0.0101	CbGpPWpGaD
Melatonin—CALM3—DAP12 interactions—FRS2—nasal cavity cancer	0.00984	0.00984	CbGpPWpGaD
Melatonin—CALM3—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00984	0.00984	CbGpPWpGaD
Melatonin—CALM3—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00984	0.00984	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR—FRS2—nasal cavity cancer	0.00975	0.00975	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00967	0.00967	CbGpPWpGaD
Melatonin—CALM3—Signaling by PDGF—FRS2—nasal cavity cancer	0.00963	0.00963	CbGpPWpGaD
Melatonin—CALM1—DAP12 interactions—FRS2—nasal cavity cancer	0.00952	0.00952	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00952	0.00952	CbGpPWpGaD
Melatonin—CALM2—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00952	0.00952	CbGpPWpGaD
Melatonin—CALM1—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00952	0.00952	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00952	0.00952	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—FRS2—nasal cavity cancer	0.00952	0.00952	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR—FRS2—nasal cavity cancer	0.00944	0.00944	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR—FRS2—nasal cavity cancer	0.00944	0.00944	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00935	0.00935	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00935	0.00935	CbGpPWpGaD
Melatonin—CALM2—Signaling by PDGF—FRS2—nasal cavity cancer	0.00931	0.00931	CbGpPWpGaD
Melatonin—CALM1—Signaling by PDGF—FRS2—nasal cavity cancer	0.00931	0.00931	CbGpPWpGaD
Melatonin—CALM3—B Cell Activation—FRS2—nasal cavity cancer	0.00911	0.00911	CbGpPWpGaD
Melatonin—CALM1—B Cell Activation—FRS2—nasal cavity cancer	0.00881	0.00881	CbGpPWpGaD
Melatonin—CALM2—B Cell Activation—FRS2—nasal cavity cancer	0.00881	0.00881	CbGpPWpGaD
Melatonin—CALM3—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00872	0.00872	CbGpPWpGaD
Melatonin—CALM2—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00843	0.00843	CbGpPWpGaD
Melatonin—CALM1—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00843	0.00843	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—FRS2—nasal cavity cancer	0.00767	0.00767	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—FRS2—nasal cavity cancer	0.00767	0.00767	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—FRS2—nasal cavity cancer	0.0067	0.0067	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—FRS2—nasal cavity cancer	0.00649	0.00649	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—FRS2—nasal cavity cancer	0.00649	0.00649	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00414	0.00414	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.004	0.004	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.004	0.004	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—FRS2—nasal cavity cancer	0.00382	0.00382	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—FRS2—nasal cavity cancer	0.0037	0.0037	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—FRS2—nasal cavity cancer	0.0037	0.0037	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—FRS2—nasal cavity cancer	0.00367	0.00367	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—FRS2—nasal cavity cancer	0.00355	0.00355	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—FRS2—nasal cavity cancer	0.00355	0.00355	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CXCL11—nasal cavity cancer	0.0035	0.0035	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CXCL11—nasal cavity cancer	0.00244	0.00244	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CXCL11—nasal cavity cancer	0.00236	0.00236	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CXCL11—nasal cavity cancer	0.00236	0.00236	CbGpPWpGaD
Melatonin—CALM3—Immune System—FRS2—nasal cavity cancer	0.00223	0.00223	CbGpPWpGaD
Melatonin—CALM1—Immune System—FRS2—nasal cavity cancer	0.00215	0.00215	CbGpPWpGaD
Melatonin—CALM2—Immune System—FRS2—nasal cavity cancer	0.00215	0.00215	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—FRS2—nasal cavity cancer	0.00206	0.00206	CbGpPWpGaD
Melatonin—CALM3—Disease—FRS2—nasal cavity cancer	0.00206	0.00206	CbGpPWpGaD
Melatonin—CALM1—Disease—FRS2—nasal cavity cancer	0.00199	0.00199	CbGpPWpGaD
Melatonin—CALM2—Disease—FRS2—nasal cavity cancer	0.00199	0.00199	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—FRS2—nasal cavity cancer	0.00144	0.00144	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—FRS2—nasal cavity cancer	0.00139	0.00139	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—FRS2—nasal cavity cancer	0.00139	0.00139	CbGpPWpGaD
